BVA Scottish Branch President Grace Webster said: "We commend the Scottish Government on seizing the opportunity to improve animal welfare through the introduction of a Bill to ban of the use of wild animals in travelling circuses. While the use of wild animals in travelling circuses may not affect a great number of individual animals, it is emblematic of the way we treat all animals and we would urge the rest of the UK to follow this precedent, introduced on ethical grounds.
"However, this package of measures seems a bit of a mixed bag. Until recently Scotland also led the way on dog welfare with a complete ban on tail docking, so we are extremely disappointed at the decision to reverse this stance. We have carefully considered all the evidence and remain convinced that tail docking in dogs, even specific breeds, is detrimental to their welfare. This is a retrograde step for animal welfare in Scotland, amidst an otherwise progressive package of animal welfare measures."
At the end of May, BVA Scottish Branch Junior Vice President Melissa Donald will be giving evidence to the Environment Committee in the Scottish Parliament ahead of a vote on whether or not to approve the change in law relating to tail docking.
Today’s announcement by the Cabinet Secretary for Environment, Climate Change and Land Reform Roseanna Cunningham MSP also included the introduction of controls to restrict the use of electronic training collars and a commitment to update regulations to combat the irresponsible breeding and sale of dogs, cats and rabbits.
Gudrun Ravetz, BVA President, added: "Animal welfare starts right at the beginning of a pet’s life, so the focus on pet licensing and breeding regulations is welcome. We know that a third of vets are seeing puppies they believe to have been illegally imported and an increasing number of owners are buying brachycephalic or designer breeds, like Scottish fold cats; pets must be purchased with owners prioritising animal health and welfare, rather than making an impulse buy based on looks alone.
"Yet we are saddened at the shortfall on legislation around aversive training aids for dogs, which we expect will still permit the use of training collars under expert guidance. We know using fear as a training tool is not only less effective than positive reinforcement, but can take its toll on a dog’s overall welfare. Without an outright ban, we have grave concerns over how enforceability will work. This raft of measures seems to give with one hand and take away with the other."
The divestment is expected to be concluded in mid-2020, and Bayer intends to exit its stake in Elanco over time.
Bayer says that combining Elanco and Bayer Animal Health will create the number two animal heath company, with top three positions across a broad range of species and geographies. It also enhances Elanco’s portfolio of leading global brands and bolsters its innovation capabilities and R&D pipeline.
Jeffrey N. Simmons, president and chief executive officer of Elanco, said: "Combining Elanco’s strong relationship with veterinarians and Bayer’s leadership in retail and e-commerce will ultimately benefit all our customers. We look forward to joining our complementary portfolios and capabilities to build a fully focused animal health company, providing a sustained flow of innovation for farmers, veterinarians and pet owners."
Boehringer Ingelheim Vetmedica has launched Benefortin (benazepril hydrochloride), an ACE inhibitor licensed for the treatment of congestive heart failure (CHF) in dogs. It is also licensed for the treatment of chronic renal insufficiency (CRI) in cats.
Benefortin uses novel micro-cap technology to mask the taste of the bitter molecule. According to Boehringer, this ensures that Benefortin tastes good1, even if it is bitten, crunched or chewed. The company says taste tests demonstrated 100% palatability in dogs and 92% palatability in cats in home settings1.
Benefortin is available in 5mg and 20mg tablets for dogs and 2.5mg tablets for cats and dogs.
Jemima Scott, Boehringer Ingelheim brand manager said: "The addition of Benefortin to our cardiology portfolio now enables us to provide veterinary practices with two of the cornerstones of canine CHF treatment, and the palatability of Benefortin makes it an excellent choice for vets needing to prescribe an ACE inhibitor."
To support the launch of Benefortin, Boehringer is offering veterinary practices the opportunity to win one of three Bosch microwave ovens in a prize draw by answering three multiple choice questions on the ACE inhibitor.
For further information on Benefortin, contact your local Boehringer Ingelheim Vetmedica territory manager or telephone 01344 746959.
Dechra Veterinary Products has launched Buprenodale, an opioid analgesic for cats, dogs and horses presented in a 10ml multi-dose vial.
Carol Morgan, Brand Manager said: "Following on from the introduction of Comfortan and Anesketin, our Buprenodale Multidose, 0.3 mg/ml solution for injection for dogs, cats and horses, is the latest addition to the portfolio.
"The active substance in Buprenodale is buprenorphine, the most commonly used opioid analgesic in small animal practice in the UK.
"Buprenodale Multidose joins a portfolio of Dechra products covering a wide range of species, different levels of analgesic efficacy and duration of action.
"The product is now available in a 10 ml multidose vial. It is suitable for post-operative analgesia in dogs and cats; post operative analgesia, in combination with sedation, in horses and potentiation of the sedative effects of centrally acting agents in the dog and horse."
For more information www.dechra.co.uk .
The RCVS Disciplinary Committee has restored a veterinary surgeon who had previously been convicted of fraud to the Register, after finding him fit to resume practising.
Matthew Morgan had pleaded guilty to four counts of fraud in July 2013 having fraudulently claimed over £200,000 in pet insurance claims between November 2009 and December 2012. In August 2013 he was sentenced to two years’ imprisonment, for which he served 12 months and was then released on licence.
Following his conviction and sentence, his case was brought to the RCVS Disciplinary Committee in February 2014 where it was decided to strike him off the Register. When his licence period expired on 18 August 2015, Mr Morgan applied for restoration to the Register.
During the course of the hearing, the Disciplinary Committee heard evidence from Mr Morgan, who accepted the findings of the Committee, describing the evidence as ‘fair’ and acknowledging the seriousness of his actions.
The Committee felt that Mr Morgan’s criminal conduct was very grave, as reflected in his custodial sentence and the fact that, as an Australian citizen, he had been issued with a deportation notice by the Home Office. It also felt that his crime had struck at the heart of public confidence in a profession for which honesty and integrity is expected.
However, the Committee considered that Mr Morgan, if restored, would pose few risks in respect of protection of the public, having no concerns about his competence as a veterinary surgeon, and accepted that there was little future risk to animal welfare if he were to be restored.
The Committee also considered that, since his release from prison, Mr Morgan has taken extensive steps to rehabilitate himself, has undertaken continuing professional development and has been working as a veterinary care assistant at two veterinary practices to keep up-to-date with current practice.
Furthermore, the Committee was satisfied that there was public support for Mr Morgan continuing as a veterinary surgeon given the references and testimonials submitted on his behalf.
In coming to its conclusion the Disciplinary Committee reiterated the seriousness of Mr Morgan’s criminal offending, saying that it had caused it “the greatest concern”. However, it also felt that issues of rehabilitation needed to be considered.
Professor Alistair Barr, chairing the Committee and speaking on its behalf, said: “The Committee cannot emphasise enough the fact that veterinary surgeons who commit acts of fraud in the exercise of their practice can expect severe consequences, both in the criminal courts and within their own College and there can be no doubt that the decision to remove the applicant from the Register was a proper reflection of the seriousness of his offending.
“Given all of the matters referred to above, however, the Committee considers that the applicant has demonstrated sufficiently that he has learned the lessons required and is now fit to be restored to the Register.”
The two companies have agreed to jointly discover and develop species-specific therapeutic monoclonal antibodies for companion animals, a class of drug which they say is neglected in veterinary medicine but offers a variety of future therapeutic options for diseases that cannot be adequately treated today.
adivo will select species-specific antibodies using its proprietary fully canine phage display library. Bayer Animal Health will provide targets involved in severe animal diseases.
Dr. Douglas Hutchens, Bayer Animal Health’s Head of Drug Discovery, External Innovation & Chief Veterinary Officer, said: "Today’s agreement is another example of how we realize our innovation strategy
"By combining the know-how from creative start-up companies like adivo with opportunities derived from Bayer’s research, we broaden our space of therapeutic medicine options and complement our portfolio.
"We are constantly looking for innovative technologies that enable us to generate novel treatment options for the companion animal sector. Now, we will focus on evolving the options presented by adivo from research and development to market maturity."
Dr. Kathrin Ladetzki-Baehs, Managing Director of adivo said: "At adivo, we truly believe that pets have a positive impact on our society. By developing novel medicines for companion animals, we want to make a difference for veterinarians and pet-parents. Today, we are more than pleased and excited to have gained such a committed and experienced collaboration partner, to jointly develop new treatment options."
In mid-September, the Association wrote to the RCVS expressing concern about the August extension to the temporary guidance.
In the latest update from the RCVS, the temporary measure has now been extended to 31 October but the flowchart and guidance have been updated to add some additional steps before a POM-V product can be prescribed remotely.
The BVA says that while it supported the original decision in March as a pragmatic solution and direct response to government restrictions surrounding Covid-19, it is now questioning the ongoing need for such a relaxation in the rules.
In the letter to the RCVS, the BVA also asked for a timeframe for the publication of the results of the RCVS survey of practices’ experiences of remote consulting and prescribing. The Association's own under care working group, chaired by Nigel Gibbens, has been developing a position to respond to the RCVS review.
BVA President James Russell (pictured right) said: "We understand that allowing remote prescription of POM-Vs was a necessary measure at the height of the lockdown, as practices struggled to assess patients in person.
"However, the veterinary professions have done a fantastic job in adapting to the restrictions and are now able to work safely and see patients.
"Whilst we recognise the RCVS has provided additional guidance for the remote prescribing of POM-V, we cannot currently see any reason why a new client would be unable to access in-person veterinary care in the first instance and we are asking RCVS Council to reconsider this measure when it meets in Oct.
"It makes sense to continue allowing vets to remotely prescribe for existing patients, for example if an owner is shielding, but we feel it is no longer appropriate to be remotely prescribing to animals that have never been physically examined by the vet.
“The question of whether we should be able to remotely prescribe POM-V products without first seeing an animal is an important and live debate, and we welcome the resumption of the College’s review. But the longer that temporary measures are in place, the greater the expectation from animal owners that they will always be in place, and the harder it will be to have the discussion about the best way forward.
“As a profession, we are rightly concerned about antimicrobial resistance and we pride ourselves on the responsible use of medicines. Continually extending the temporary measures without a full analysis would risk undermining our position.”
The virtual collection provides a source of evidence to determine what is or is not of clinical significance in cardiac arrhythmia and what might represent the best course of action, if action is needed, within the requisite parameters of safety and welfare.
With an editorial written jointly by Peter Physick-Sheard and Joann Slack the virtual collection includes:
... and more.
Professor Celia Marr, Editor of the EVJ said: “In terms of day-to-day veterinary work, rhythm disturbances are a frequent frustration during prepurchase examinations or perceived poor performance assessments. This outstanding collection brings to hand the most recent evidence to help clinicians support their observations, facilitating diagnosis and a treatment plan in this challenging area.”
The Virtual issue can be downloaded here: https://beva.onlinelibrary.wiley.com/doi/toc/10.1111/(ISSN)2042-3306.irregular-hearts-performance.vi
The new distribution service uses Invatech's Patient Medication Record (PMR) system, called Titan, which was accredited by the NHS a little over a year ago. Titan has now been developed further to support the company's Home Pharmacy service, and integrate with MWI.
The company says the new system offers practices a seamless workflow between prescribing, dispensing and logistics systems.
Tariq Muhammad, CEO of Invatech Health, said: "“The use of PMR systems for the veterinary market has been very light touch until now. Knowing that that we can bring the same level of efficiency and workflow to a new market presents an opportunity to support animal health in the same way that we do for human health."
Alan White, Commercial Director at MWI Animal Health, said: “The Covid pandemic has presented many challenges to veterinary professionals in the UK. Travel restrictions and social distancing measures make it difficult for animal owners to collect the medications and treatments they need from veterinary practices.”
“We are excited to be able to work with Invatech to provide an innovative solution to this problem, where vets can send the medications needed directly to their client. Working in partnership with veterinary practices and Invatech means we can move animal health forward together.”
For more information, visit: https://www.invatechhealth.com/
The new programme, which starts in May 2021, will address the fundamental principles underlying cardiac disease, discuss common presentations and review current diagnostic and therapeutic techniques.
Modules are delivered using a range of blended learning techniques, including interactive online lessons, supported by notes and videos.
While studying, delegates will have a module tutor – a recognised veterinary Specialist in their field - and a dedicated programme tutor, who works with individual delegates to support them through the programme.
Delegates can also choose three optional practical attendance sessions covering ECGs, thoracic radiography and echocardiography.
The programme offers a route through to achieving academic qualifications - General Practitioner Certificate (GPCert) and the Postgraduate Certificate (PgC), in partnership with the International School of Veterinary Postgraduate Studies (ISVPS) and Harper Adams University. Gaining a PgC enables delegates to apply to RCVS for Advanced Practitioner status in the subject.
Course Director Kieran Borgeat BSc BVSc MVetMed CertVC DipACVIM DipECVIM-CA MRCVS, said: "Improve International’s Cardiology DL programme features a diverse array of speakers from a variety of backgrounds, who will bring the latest information about veterinary cardiology to delegates. Our module leaders are world experts in their field so bring a thorough and uniquely engaging approach to the course material. Being able to discuss the topic with them and other course delegates online during each module of teaching during a two-year, in-depth course is a fantastic opportunity to connect with the topic as never before."
David Babington MRCVS, Business Development Director at Improve International, said: “Our cardiology programme has been designed to equip delegates with all of the skills and knowledge they need to confidently investigate, diagnose and treat cardiac patients.
“As we start to look ahead to a time beyond lockdowns, many veterinarians are taking stock and considering the next step in their career. For some, an additional qualification may be part of their plan. By offering a distance learning solution, we can ensure that, wherever in the world they are in practice, they have the opportunity to develop their clinical skills and achieve a postgraduate qualification.”
Registration information can be found here: https://www.improveinternational.com/uk/course/pgc-gpcert-small-animal-cardiology-distance-learning/
Dechra Veterinary Products, maker of the feline hyperthyroidism treatment Felimazole®, has launched a range of waiting room materials for practices to raise awareness with owners about the disease.
Using Dechra's cartoon cat, which already features in their client booklets on feline hyperthyroidism, the materials are intended to create a focal point in the waiting room, with factual posters detailing what feline hyperthyroidism is and the symptoms to look out for. Also included is a selection of display enhancers.
The new waiting room display has been designed to complement Dechra's existing materials: client booklets, the website www.hyperthyroidcat.co.uk, website posters and hand-out cards.
Matthew Olsen, product manager at Dechra Veterinary Products said: "Our complete range of materials makes it easier for practices to communicate with owners on the subject and will help owners better understand and manage hyperthyroidism in their cats".
Practices can order their pack of waiting room materials by contacting Dechra on 01743 441632 or email marketing@dechra.com.
New legislation will be introduced in the New Year making slaughterhouse CCTV a legal requirement in all areas where live animals are present, with unrestricted access to at least 90 days of footage for Official Veterinarians. The new law will come into force in the spring, with slaughterhouses allowed an adjustment period of up to six months.
The new legislation followed a public consultation which was overwhelmingly in favour of compulsory CCTV. Defra says that out of almost 4,000 respondents, more than 99% were supportive of the plans.
Environment Secretary Michael Gove said: "We have some of the highest animal welfare standards in the world and want to cement our status as a global leader by continuing to raise the bar.
"The reaction to this consultation highlights the strength of feeling among the public that all animals should be treated with the utmost respect at all stages of life and be subject to the highest possible welfare standards.
"These strong measures also provide a further demonstration to consumers around the world that as we leave the EU we continue to produce our food to the very highest standards."
BVA Senior Vice President Gudrun Ravetz said: "The mandatory installation of CCTV is a vital tool to ensure high standards of animal health, welfare and food safety in all slaughterhouses.
Official Veterinarians carry out an essential role in slaughterhouses by independently assessing and reporting breaches of animal welfare, and unrestricted access to CCTV footage will allow them to carry out this role even more effectively.
We have been campaigning for these measures for a number of years and it is reassuring to see such a high level of support for their implementation from industry and the public."
Heather Hancock, Chairman of the Food Standards Agency, said: "The Secretary of State’s decision to require CCTV in all slaughterhouses is a welcome step towards ensuring that animal welfare and hygiene standards are met across the meat industry.
"Last year, the FSA Board concluded that, without mandatory CCTV in slaughterhouses, we would see minimal further progress in businesses improving animal welfare or complying with official controls to protect public health.
"We look forward to working with the industry as CCTV plans are implemented, and to seeing public confidence rise as a result."
The government will now further discuss the details of bringing in the proposals and present draft legislation to Parliament as soon as Parliamentary time allows.
Photo: Lititz, Pennsylvania. Hoisting a slaughtered steer in Benjamin Lutz's slaughterhouse, 1942. Wikipedia.
The four organisations have written a template letter which anyone can send to any company they see using brachycephalic breeds, such as the Persian, or Scottish Folds, in its marketing materials.
The letter urges companies that use images of cats to work collaboratively with veterinary professionals and pledge to avoid using such breeds in the future.
Dr Nathalie Dowgray, Head of ISFM, said: “Seeing a cute cat in an advertisement can often be a trigger for people to seek out acquiring a cat of that breed without understanding the welfare concerns associated with some pedigree breeds.
"A rise in demand can lead to an increase in breeding practices that result in severe conformational issues and poorer welfare in these breeds.
"We encourage people to download this letter to use when they see breeds of concern being used in advertising, as health is always more important than looks.”
https://icatcare.org/app/uploads/2023/09/ISFM_FECAVA_FVE_UEVPAdvert_Letter.pdf.
Woodley Equipment Company has announced that Veterinary Parasep Faecal Filters are now available exclusively from the company.
According to the Woodley, the filters have been developed in conjunction with an independent leading veterinary Institution and offer an improved method of determining Worm Egg Counts (WEC) on cattle, sheep and horses. Flotation methods for WEC can require several Specific Gravity solutions to cover different parasites. The two common flotation methods, ‘Modified McMaster' and ‘Improved Modified McMaster', both use Saturated NaCL and are both catered for with Veterinary Parasep.
Woodley says the key advantages of the new filters are:
For a more information about The Veterinary Parasep please email sales@woodleyequipment.com or call the customer service team on +44 (0) 1204 669033 ~ Option 1.
Alternatively, visit http://www.woodleyequipment.com/.
Dechra Veterinary Products has launched Ketodale, an anti-inflammatory injection for cattle, horses and swine.
Ketodale contains the non-steroidal anti-inflammatory drug ketoprofen 100mg/ml. It is indicated for use in cattle and swine for diseases associated with inflammation, pain or fever. In cattle these include respiratory diseases, mastitis, osteoarticular and muscular-skeletal disorders, such as lameness and arthritis, and to ease pain post parturition. Ketodale can be used to treat swine suffering from Mastitis Metritis Agalactia (MMA) Syndrome and respiratory tract infections.
In horses, Ketodale is indicated for diseases affecting the osteoarticular and muscular-skeletal system associated with pain and inflammation. These include naviculitis, arthritis and laminitis. It can also be used for post-surgical inflammation and symptomatic therapy of colic and fever.
Ketodale is available in 50ml and 100ml vials.
To coincide with the product's launch, Dechra is carrying out a direct marketing campaign. Practices can take advantage of a special launch offer where they can purchase four vials and get a fifth free. The offer is available for a limited period only.
To find out more about Ketodale, call Dechra on 01743 441 632 or visiting www.dechra.com
The courses are:
MMI Manager Lisa Quigley commented: “I am really proud of this new tranche of training.
"Whereas our previous training has focused on the individual experience, for example, mental health awareness and resilience, these new courses recognise that individual instances of poor mental health and wellbeing can often be caused by systemic issues – whether that’s a poor workplace culture where bullying and incivility thrive, or discrimination on account of someone’s protected characteristics.
The full range of courses, including the dates and times and details on how to register, can be found at www.vetmindmatters.org/training
Feedback about any of the courses can be sent to info@vetmindmatters.org
Agrimin has announced the launch of a new range of boluses for sheep and cattle that use 'eroding technology' to deliver a sustained supply of three trace elements for up to 180 days:
According to Agrimin, each bolus is designed to provide the full daily requirement of cobalt and selenium and the largest available daily supply of iodine to both cattle and sheep. The boluses do not contain any copper, an element known to cause issues in certain parts of the country, in closely managed dairy cows or in continental sheep breeds.
Each bolus is made up of two parts, held together by a soluble wrapper. After administration, the wrapper dissolves and the two halves remain in the reticulum where they erode and dissolve. This process delivers a continuous and regular supply of nutrients to the animal.
Agrimin's Dr Jamie Bennison said that the new range has been extensively trialled in New Zealand and at Glasgow Veterinary School: "Trials have confirmed a sustained release profile which ensures that iodine, selenium and cobalt levels are maintained throughout the active life of the bolus. In farm trials this has translated into higher levels of the elements in blood samples and improved animal productivity."
Treatment is one bolus per animal (48g for sheep; 160g for cattle) administered with an Agrimin bolus gun. One bolus is sufficient to meet the animal's full daily requirement for 180 days.
For more information about the 24•7 Iodine•Selenium•Cobalt range of cattle and sheep boluses, please visit http://www.agrimin.com/ or call 01652 688046.
The RCVS has introduced a new online recording system for graduates starting their Professional Development Phase (PDP).
The new PDP database sits as a module within the Professional Development Record (PDR), launched by the RCVS in April to help veterinary surgeons and veterinary nurses plan, evaluate and record their CPD.
Freda Andrews, RCVS Head of Education said: "Bringing the PDP into the new Professional Development Record shows clearly how this stage of a vet's development is part of the continuum of professional development that starts at university and continues for as long as they practise. We are also developing a system for students to record their practical and clinical experience whilst at university and, once this is complete next year, the PDR will become a complete record of professional lifelong learning."
Like the rest of the PDR, the new PDP module offers extra space for notes, and allows documents such as case reports and presentations to be uploaded and stored. Responding to feedback from users of the old PDP system, the new interface is designed to be more user friendly than the previous PDP database, and contains interactive help, guidance on PDP and an easier means of recording case numbers against the clinical skills lists. All new graduates from 2012 are able to sign up to use the new PDP site and, once their account is activated, they will also be able to use the CPD area to record any additional CPD they might undertake.
Graduates from previous years who are still undertaking their PDP using the old database may continue on the old system for the time being, although at some stage within the next year or so, the old site will need to be archived. Anyone who would prefer to use the new system instead should contact the PDP administrator at the RCVS to discussed transferring (pdp@rcvs.org.uk 020 7202 0736). As the skills lists have changed slightly, however, an automatic transfer of data from the old to the new isn't possible.
The PDP links the 'Day One' competences that veterinary surgeons have achieved when they graduate to the 'Year One' competences which they are expected to have achieved after about a year in practice. Each vet's progress through the PDP is supervised by a Postgraduate Dean, and its completion also requires sign-off from the veterinary surgeon's employer or mentor.
For more information, or to sign up to the PDP, visit www.rcvs.org.uk/pdp.
The Action Plan presents what the College is doing to tackle the issue and explains how collaboration, culture change, career development and leadership, among other things, could help with workforce shortages by improving retention of current members of the professions, encouraging more people to join, and making it easier for those who have left the professions to return.
The report lists seven main areas to be addressed:
The full list of actions, with context about what has fed into ambitions, can be found in the Action Plan which is downloadable at www.rcvs.org.uk/publications.
Dr Sue Paterson FRCVS, Junior Vice-President and Chair of the RCVS Advancement of the Professions Committee, said: “This is a very complex, broad and multi-faceted area of concern so the Action Plan has been a long time in the making to ensure that we adequately capture what needs doing and how, in order to enable us to work collaboratively with all veterinary organisations going forward.
"This is not a finished list, but gives all within the veterinary sector the ability to look at the key areas of work that need to be done and prioritise the ones that most suit their organisational needs."
Bayer Animal Health has announced that its parasiticide - Advocate Spot-On Solution - is now licensed to be used weekly, and for a prolonged period of time, in severe cases of demodicosis in dogs.
According to the company, recent work carried out to obtain the new weekly indication shows a number of benefits of this increased application frequency for severely affected animals. Dogs treated on a weekly basis showed a greater reduction in mite numbers, fewer clinical signs, and improved hair regrowth and weight gain over the trial period, when compared to dogs treated monthly.
Advocate remains licensed for monthly use on mild to moderate presentations.
A spokesperson for the company said: "The new claim for the weekly use of Advocate should give veterinary surgeons a more effective route to go down when dealing with more severe cases, compared to monthly use. However, demodicosis is a complex condition which presents the practitioner with many challenges. So, from past experience with this condition, we would urge vets to be patient and also recognise the importance of treating any underlying disease process likely to exacerbate the situation."
Advocate Spot-on Solution has also been recently licensed for the prevention of Angiostrongylus vasorum, and the treatment of Crenosoma vulpis.
For further information, please contact your Bayer representative or the Bayer technical advice line on 0845 1305995.
Davies Veterinary Specialists (DVS) has announced that it has completed development work on its premises in Higham Gobion, Hertfordshire, to improve capacity and workflow for diagnostic procedures including MRI, CT and endoscopy.
The new development includes the construction and outfitting of an anaesthesia induction room with two state-of-the art stations, a diagnostic imaging viewing room, a further ultrasound and procedures room and office space for the nurse supervisor team. The rooms were built inside the site’s central barn as the next phase of DVS’s ongoing expansion programme, which has recently seen the completion of a new staff room and upgraded kennels and cattery facilities.
Clive Elwood, Managing Director of DVS said: “We first acquired the barn space in 2004 and initial construction included MRI and CT rooms with the plan of completing further rooms as needs arose. This latest development has already had a big impact on workflow and allows us to optimise the use of our diagnostic equipment. It represents our continued commitment to growth and development so that we can serve our customers to the best of our ability. I am very grateful to all of those who contributed to the project and showed necessary patience during construction.”
DVS now employs more than 35 specialist clinicians, 60 nurses, many with an advanced nursing qualification, and 30 administrators and support staff.
For further information visit www.vetspecialists.co.uk. You can also follow DVS on Facebook at http://www.facebook.com/DVSvets.
New subject areas include emergency planning, traffic accidents, excessive bleeding, seizures, poisonings, choking and breathing problems, caesareans, GDV and abdominal emergencies, and pain assessment and management.
ECC is the first element of the new Practical and Clinical Skills section of the BSAVA’s online Professional Development Phase (PDP) Resource Bank, and takes the total to more than 100 hours of free online CPD support matched directly to the RCVS PDP competences.
The BSAVA PDP resource bank is designed to help veterinary surgeons to enhance practice expertise, develop their practices’ professional and business skills, and advance an ethos of reflective learning and continuous professional development (CPD) alongside veterinary expertise.
Members can pick and choose the most appropriate content for their professional development from more than 250 resources in multiple formats to suit a range of learning preferences, including short ‘how to’ videos, webinars written by and featuring veterinary specialists, podcasts, documents and interactive PDFs and web links.
BSAVA President John Chitty said: "BSAVA continues to lead the way in CPD learning resources and this easily accessible and flexible PDP Resource Bank has proven very popular in helping members to meet the challenges of delivering 21st century veterinary medicine."
The BSAVA PDP Resource Bank content is reviewed by committee and there will be ongoing development of new resources – including employer specific resources for practices supporting new graduates.
For more information visit www.bsava.com/pdp
A quick poll carried out by Michael Woodhouse amongst the members of VetSurgeon suggests that the majority of UK veterinary surgeons do not brush their own dog's teeth.
98 members took part in the survey, as follows:
New research led by academics at the University of Bristol's School of Veterinary Sciences has shown that 85% of pet cats are not neutered by the recommended age of four months, possibly due to cat owners needing better information about when to neuter their cat.
In 2006, the recommended neutering age of pet cats reduced from six to four months of age. The study assessed the proportion of cats neutered at these ages. Data was obtained from owner-completed questionnaires at recruitment, when kittens were aged eight to 16-weeks, and six and a half to seven months of age. Demographic and lifestyle factors were also assessed for potential association with neuter status.
The researchers found that of the 751 cats in the study, 14.1% and 73.5% had been neutered at or before four and six months of age, respectively. Cats were significantly more likely to be neutered at four months if their owners had always intended to have their cat neutered by this age. They were also significantly more likely to be neutered at four months if they were microchipped or from households in deprived regions.
The likelihood of being neutered, compared with unneutered, at six months of age was significantly increased for cats that were insured, obtained from an animal welfare organisation, given their second vaccination, from a household with an annual income of over £10,000 and owned by people intending to have their cat neutered by this age.
Dr Jane Murray, Cats Protection Research Fellow in Feline Epidemiology, said: "Neutering is recommended as an effective way of reducing the number of unwanted cats in the UK. Our study found that age of neutering was associated with the age of intended neutering. Cats can reach puberty at four to five months of age therefore, it is important that owners are aware of the recommended age of neutering at four months, to reduce the number of unplanned pregnancies that occur."
The study suggests that while neutering rates were high at six months of age, they were low at four months of age, and that further work is required to publicise the recommended neutering age of four months to cat owners.
Paper: The neuter status of cats at four and six months of age is strongly associated with the owners' intended age of neutering, C. P. Welsh, T. J. Gruffydd-Jones and J. K. Murray, Veterinary Record published online April 19, 2013.
MSD Animal Health (Merck in the US and Canada), has launched Finadyne (flunixin), the NSAID for cattle, as a pour on.
According to the company, Finadyne Transdermal is the world's first non-parasiticide cattle product to be made available as a pour-on.
Dr. Martin Behr, technical manager at MSD Animal Health said: “Finadyne Transdermal is uniquely designed for rapid absorption into the bloodstream and its antipyretic effect has been demonstrated as early as two hours after treatment. This is because innovative penetration enhancers are included in the formulation to improve the absorption of the active ingredient flunixin through the skin.”
The new product comes in pre-calibrated packaging and uses a bottle designed for easy application along an animal’s back.
Dr. Behr added: “It’s much simpler for farmers to treat cattle in this way – as opposed to administering an injection, which can also mean needle-site lesions that can reduce the value of a carcass or compromise hide quality.
“The time taken to handle and treat animals will be much reduced with a transdermal NSAID. There will also be a saving on syringes and needles.”
Finadyne Transdermal (POM-V) is available now from veterinary wholesalers. Further information is available from the MSD Animal Health veterinary support group on 01908 685685.